Back to VA VANGUARD CAPITAL MANAGEMENT LLC
JANX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in JANUX THERAPEUTICS INC
Yes. Vanguard Capital Management holds 1,857,351 shares of JANX (Janux Therapeutics), worth $28.5M, as of its Q2 2026 13F filing. It increased the position by 45,986 shares (+2.5%) from Q1 2026. Vanguard Capital Management has held JANX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$28.5M
Current Shares
1.9M
Total Value Change
+$3.4M
Total Shares Change
+45,986
Quarter-by-Quarter History
Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC